Journal
The New England Journal of Medicine
Publication Date
2016
Volume
375
Issue
21
Inclusive Pages
2023-2036
Document Type
Open Access Publication
DOI
10.1056/NEJMoa1605949
Rights and Permissions
Welch, J. S., Petti, A. A., Miller, C. A., Fronick, C. C., O'Laughlin, M., Fulton, R. S., . . . Ley, T. J. (2016). TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes. New England Journal of Medicine, 375(21), 2023-2036. doi:10.1056/NEJMoa1605949. Copyright © 2016 Massachusetts Medical Society. DOI: 10.1056/NEJMoa1605949. http://www.nejm.org/doi/full/10.1056/NEJMoa1605949.
Recommended Citation
Petti, A. A.; Miller, C. A.; Fronick, C. C.; O'Laughlin, M.; Fulton, R. S.; Wilson, R. K.; Wartman, L. D.; Ley, T. J.; and et al, "TP53 and decitabine in acute myeloid leukemia and myelodysplastic syndromes." The New England Journal of Medicine. 375, 21. 2023-2036. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5419
